Hemotune

Series-B
hemotune.ch Biotech & Healthcare Schlieren, Switzerland
Total Funding $28.7M
Latest Round $15.5M Series-B
Last Announced Mar 25, 2024
Investors 7 Backers
Decision Makers 5 Available

About Hemotune

Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Schlieren, Switzerland
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website hemotune.ch
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $15,520,000 · Series-B

    Backed by Belmondo

  2. Capital Raise

    Raised $7,560,000 · Series-B

    Backed by OCCIDENT

  3. Capital Raise

    Raised $5,580,000 · Series-A

    startupintros.com

Investors & Backers

7
Belmondo
Lead
OCCIDENT
Lead
EFI Lake Geneva Ventures
Hemex
Innosuisse
VP Venture Partners
Zürcher Kantonal Bank

Funding History

3 Rounds
Series-B equity · Mar 25, 2024

Round backers: Belmondo

Series-B equity · Apr 26, 2022

Round backers: OCCIDENT

Series-A equity · Aug 12, 2020

Founders & Leadership

3

Carlos Mora

Founder

Work email & phone locked Unlock →

Christian Brühlmann

Chief Business Officer

Work email & phone locked Unlock →

Lukas Langenegger

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts